Drug interaction and its implication in clinical practice and personalized medicine
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2015, Vol 5, Issue 5
Abstract
In personalized medicine, the appropriate drugs for an individual patient are selected based on the patient’s medical history, diagnostic testing, and genetic information for the purpose of minimizing drug interactions (DIs), side effects, and adverse drug reactions (ADRs) and to obtain the maximum therapeutic benefit. The DI is one of the major problems of pharmacotherapy, which perhaps leads to adverse outcome or therapeutic failure if not properly addressed. In clinical practice, patient safety is likely to improve through the identification of frequently occurring DIs by pharmacist and notifying the other members of the health-care team. Recently, a software was introduced, which detects DIs with good precision; however, this software requires a constant update. Health-care professionals require adequate knowledge and skills on how to identify and avoid DIs to enable them complement the software assessment. Basically, DIs include drug–drug, drug–food, drug–herbal, and drug–disease interactions. These possibilities can be identified from chemical properties, pharmacokinetics, and pharmacodynamics of the drug, patient medical history, concomitant disease, or organ failure. Focusing on DIs will help to reduce drug-related problems, advance the evidence-based medicine, and improve the level of patient satisfaction. Adequate knowledge of drug DIs will enable the health-care professionals to individualize the patient treatment in order to get maximum therapeutic benefit. This script is aimed at describing the various classes of DIs, their causes, and their implications in clinical practice and personalized medicine.
Authors and Affiliations
Abdullahi Rabiu Abubakar, Bashir AZ Chedi, Khalid Garba Mohammed, Mainul Haque
Keywords
Related Articles
- EP ID EP101615
- DOI 10.5455/njppp.2015.5.2005201557
- Views 58
- Downloads 0
Quercetin improved spatial memory dysfunctions in rat model of intracerebroventricular streptozotocin-induced sporadic Alzheimer’s disease
Background: Alzheimer’s disease (AD) is one of the most common neurodegenerative syndromes characterized by a progressive decline in the spatial memory. There are convincing evidences on the neuroprotective effect...
Short-term memory and verbal fluency in Type 2 diabetes
Background: Neuropathy is common in people with Type 2 (non-insulin-dependent) diabetes for a long duration. Hence, it is possible that deficits in cognitive function might also be found in those who have had diabetes fo...
In vitro antifungal effect of Rosmarinus officinalis essential oil on Aspergillus niger
Background: The development of Aspergillus niger fungi at the surface and in the food products is indeed very often seen, especially in the tins. It is essential to find a solution for a better conservation using natural...
An in vitro study of antibacterial and antifungal activity of Cynodon dactylon
Background: Plant-derived antimicrobial agents remain an arena for research to overcome the issues pertaining to microbial resistance and adverse effects associated with synthetic drugs. Aims and Objectives: The present...
Development of gel composition and technology based on pyrimidine substance
Background: This work was conducted in the framework of quality by design project involving the production of a pharmaceutical gel. Preliminary work included the identification of the quality target product profiles from...